News Focus
News Focus
Followers 5
Posts 364
Boards Moderated 0
Alias Born 09/28/2014

Re: fbg0316 post# 18128

Wednesday, 04/12/2017 6:49:09 PM

Wednesday, April 12, 2017 6:49:09 PM

Post# of 108195
Actually, to me it seems obvious that the shorts/manipulators etc. are having their way with ADXS because of the extended timeline regarding the current Phase 3 which is as an adjuvant not even first line......so, basically any short term catalyst will be essentially a binary event coming from unknown source/event and unknown timing. So basically, place your bet and spin the wheel....it will be black or red.....EMA approval, combo with Merck, combo with Astra, etc, etc. EU partner, etc, etc.

with binary events, the results can go your way or the other way----no way to know in advance. With clinical stage bio's the odds are against so the short thesis is the results will be bad but even if not they will take their chance covering at news of the event or shortly after when the manipulators try to short it back down. Time alone will tell who the winners or losers will be.
I will keep my 75,000 shares/warrants bet on success.

GLTAL's

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today